Literature DB >> 8013563

In vivo regulation of extracellular adenosine levels in the cerebral cortex by NMDA and muscarinic receptors.

M Pazzagli1, C Corsi, S Latini, F Pedata, G Pepeu.   

Abstract

The adenosine concentration in samples of perfusate was determined 24 h after implantation of microdialysis fibre in the cortex. High performance liquid chromatography coupled with a fluorometric detector was used. K+ (100 mM) depolarization was followed by a 2- to 4-fold increase in adenosine efflux. The addition of tetrodotoxin (1 microM) to the perfusate was followed by a decrease in spontaneous and K(+)-evoked adenosine efflux. The increase induced by high K+ was markedly inhibited by the NMDA receptor antagonist, D(-)-2-amino-7-phosphonoheptanoic acid (1 mM, D-AP7), but not by the muscarinic receptor antagonist, atropine (1.5 microM). The acetylcholine esterase inhibitor, physostigmine (7 microM), and the muscarinic receptor agonist, oxotremorine (100 microM), significantly enhanced the K(+)-evoked increase in adenosine. The spontaneous efflux of adenosine was not modified by any of the drugs tested. A neurotoxic lesion of the cholinergic pathway innervating the cortex, although inducing a marked decrease in cortical choline acetyltransferase activity, did not significantly modify the cortical adenosine efflux. It is concluded that, under K(+)-depolarizing conditions, adenosine efflux is triggered by excitatory amino acids and enhanced by muscarinic activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8013563     DOI: 10.1016/0014-2999(94)90465-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

1.  Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices.

Authors:  S Latini; F Bordoni; F Pedata; R Corradetti
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Quantitative analysis of adenosine using liquid chromatography/atmospheric pressure chemical ionization-tandem mass spectrometry (LC/APCI-MS/MS).

Authors:  Annelies Van Dycke; Alain Verstraete; Kristof Pil; Robrecht Raedt; Kristl Vonck; Detlev Boison; Paul Boon
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-04-03       Impact factor: 3.205

3.  Adenosine inhibits activity of hypocretin/orexin neurons by the A1 receptor in the lateral hypothalamus: a possible sleep-promoting effect.

Authors:  Zhong-Wu Liu; Xiao-Bing Gao
Journal:  J Neurophysiol       Date:  2006-11-08       Impact factor: 2.714

Review 4.  The Role of Adenosine Signaling in Headache: A Review.

Authors:  Nathan T Fried; Melanie B Elliott; Michael L Oshinsky
Journal:  Brain Sci       Date:  2017-03-13

5.  Intracerebral microdialysis of adenosine and adenosine monophosphate - a systematic review and meta-regression analysis of baseline concentrations.

Authors:  Stevie van der Mierden; Sergey A Savelyev; Joanna IntHout; Rob B M de Vries; Cathalijn H C Leenaars
Journal:  J Neurochem       Date:  2018-09-27       Impact factor: 5.372

6.  Chronic NMDA receptor stimulation: therapeutic implications of its effect on adenosine A1 receptors.

Authors:  D K Von Lubitz; J Kim; M Beenhakker; M F Carter; R C Lin; Y Meshulam; J W Daly; D Shi; L M Zhou; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1995-09-05       Impact factor: 4.432

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.